Injectable Drug Delivery 2013 Report

Research and Markets logo

Dublin, Oct. 29, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/glgdxc/injectable_drug) has announced the addition of the Injectable Drug Delivery 2013 Report to their offering.

Global Injectable Drug Delivery Technologies Market Forecast To Reach $43.3 Billion By 2017 At A CAGR Of 14.0% From 2012 To 2017

This research report categorizes the global injectable drug delivery technologies market into two segments:global injectable drug delivery devices technologies and global injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography to provide in-depth information on the global scenario.

Market Highlights

Growth drivers for the injectable drug delivery technologies market include product life cycle management, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes at global level and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as, India, and China. However, factors such as needle-stick injuries and infections, development of alternate delivery methods and product recalls are restraining the growth of the market.

North America accounted for the largest market share of 41.3% of the global injectable drug delivery technologies market, followed by Europe (30.2%) in 2012. However, the region lags behind Europe in the self injection devices market. This is owing to low penetration rate of pen injectors in the US Asian and Latin American countries represent the fastest growing markets due to growing number of cancer and diabetes incidences, and improving patent compliance. Furthermore, stringent regulatory policies for approval of medical devices, and high competition in mature countries will compel the companies to focus on the emerging markets in Latin America and Asia.

Key Topics Covered

1 Introduction

2 Executive Summary

3 Market Overview
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.4 Market Share Analysis, By Major Players

4 Global Injectable Drug Delivery Devices Technologies Market
4.1 Introduction
4.2 Market Segmentation
4.3 Manufacturers Criteria For Selection Of An Injectable Device
4.4 Conventional Injectable Drug Delvery Devices
4.5 Self-Injection Devices
4.6 Others

5 Global Injectable Drug Delivery Formulation Technologies Market
5.1 Introduction
5.2 Conventional Drug Delivery
5.3 Novel Drug Delivery Formulation Technologies

6 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications
6.1 Introduction
6.2 Auto-Immune Diseases
6.3 Hormonal Disorders
6.4 Orphan/Rare Diseases
6.5 Oncology
6.6 Others

7 Geographic Analysis

8 Competitive Landscape
8.1 Introduction
8.2 Expansion
8.3 Agreements, Partnerships, Collaborations & Joint Ventures
8.4 New Product Launch
8.5 Mergers & Acquisitions
8.6 Other Developments
8.7 Approvals

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*

Companies Mentioned

  • Alkermes
  • Antares Pharma
  • Baxter International
  • Becton, Dickinson And Company
  • Bespak Europe, Ltd. (Subsidiary Of Consort Medical, Plc)
  • Crossject
  • Elcam Medical
  • Eli Lilly And Company
  • Gerresheimer
  • Haselmeier
  • Injex Pharma (Subsidiary Of Hns International)
  • Novo Nordisk
  • Owen Mumford
  • Sanofi
  • Schott
  • Shl Group
  • Terumo Corporation
  • Unilife Corporation
  • Vetter Pharma-Fertigung
  • West Pharmaceutical Services
  • Ypsomed Holding
  • Zogenix

For more information visit http://www.researchandmarkets.com/research/glgdxc/injectable_drug

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery

Source:Research and Markets